Skip to content

'Trickle-down' education can increase safer sex practices in hard-to-reach communities

High incidence of TB after ART started, MSF reports

Second company halts CCR5 inhibitor study in another blow to new drug class

Unusual side-effects or drug interactions? UK's safety regulator wants to hear from you

Report higlights increase in HIV infections amongst IDUs in UK

Vitamin D boosts anti-TB immunity, now being tested as add-on to TB therapy

Main article: Clinical Care Options discussion on mother-to-child transmission

Blood concentrations of efavirenz predict who will develop central nervous system side-effects

Tipranavir receives European marketing approval